Loading…

Expression of chemokines and matrix metalloproteinases in early rheumatoid arthritis

Objective. To compare macrophage infiltration and expression of chemokines and matrix metalloproteinases (MMPs) in synovial tissue between patients with early and long‐standing rheumatoid arthritis (RA). Methods. Knee synovial biopsies were taken from 22 patients with early (5 yr) RA and immunostain...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2001-09, Vol.40 (9), p.988-994
Main Authors: Katrib, A., Tak, P. P., Bertouch, J. V., Cuello, C., McNeil, H. P., Smeets, T. J. M., Kraan, M. C., Youssef, P. P.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To compare macrophage infiltration and expression of chemokines and matrix metalloproteinases (MMPs) in synovial tissue between patients with early and long‐standing rheumatoid arthritis (RA). Methods. Knee synovial biopsies were taken from 22 patients with early (5 yr) RA and immunostained with antibodies specific for CD68; macrophage inflammatory protein (MIP)‐1α and monocyte chemoattractant protein (MCP)‐1; MMP‐1 and ‐3 and the tissue inhibitors of metalloproteinases (TIMP)‐l and ‐2. Immunostaining was quantified using a colour video image analysis system. Results. CD68+ macrophage infiltration and the expression of MIP‐1α, MCP‐1, MMP‐1, MMP‐3, TIMP‐1, and TIMP‐2 were observed in synovial tissue of patients with early RA. In long‐standing RA, there was a further increase in CD68+ macrophage infiltration and MIP‐1α expression in the synovial lining layer. CD68 expression correlated with MIP‐1α (R=0.39, P=0.01), but not with MCP‐1 expression. Conclusion. Macrophage accumulation, and the expression of chemokines and MMPs in synovial tissue occur in early RA. Targeting chemokines which play a role in the migration of macrophages into the joints may be of therapeutic benefit in RA patients.
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/40.9.988